title: High-dose methylprednisolone is effective in the management of acute graft-versus-host disease in severe combined immune deficiency.
authors.forename: Raz
authors.initials: R
authors.lastname: Somech
authors.forename: Fotini D
authors.initials: FD
authors.lastname: Kavadas
authors.forename: Adelle
authors.initials: A
authors.lastname: Atkinson
authors.forename: Eyal
authors.initials: E
authors.lastname: Grunebaum
authors.forename: Chaim M
authors.initials: CM
authors.lastname: Roifman
mesh_terms: D000208:Acute Disease; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D016026:Bone Marrow Transplantation; D018572:Disease-Free Survival; D005260:Female; D006086:Graft vs Host Disease / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage*; D012189:Retrospective Studies; D016511:Severe Combined Immunodeficiency / Q000235:genetics / Q000401:mortality / Q000628:therapy*
chemical_list: D000893:Anti-Inflammatory Agents; D008775:Methylprednisolone